VALUE-BASED INNOVATION FOR HIGH-RISK POPULATIONS
Supporting payers, ACOs, and VBC organizations with smarter disinfection and engagement to reduce complications, lower costs, and improve member outcomes.
WHY IT MATTERS
1 in 3 of the 38M people with diabetes in the U.S. will develop a diabetic foot ulcer (DFU) in their lifetime.¹
2.8x Higher odds of hospitalizations for diabetic foot infections (DFIs) versus without.²
+40% DFUs recur within 1 year; >65% recur within 5 years.³
57% 5-year mortality rate after diabetic limb amputation.⁴
THE CHALLENGE
Orthotics, prosthetics, and similar devices are extremely difficult to disinfect. When bacteria remain, they can re-seed wounds, driving infections and device-related complications that perpetuate a costly cycle:
-
Emergency visits and hospitalizations to manage infection
-
Surgical interventions, including amputations
-
Escalating long-term care expenses
CONTAMINATED O&P DEVICE
RE-SEEDING WOUND
INCREASED INFECTION
REACTIVE CARE IS EXPENSIVE
“One of the biggest blind spots in wound care is the device itself.
Contaminated prosthetics and footwear can reintroduce bacteria,
undermining treatment and fueling costly readmissions.”
— Board-Certified Emergency Medicine Physician
THE BLUEWAVE APPROACH FOR PAYER VALUE
OUR APPROACH
Target fewer ED visits, readmissions, and costly escalations
Support better outcomes and improved quality scores
Provide RPM, real-time utilization and adherence data to guide proactive care
Scale across high-risk cohorts while aligning to HHVBP and VBC incentives
DEVICE
Portable, FDA Class II disinfection system for at-home use
Designed for diabetic shoes, offloading boots, prosthetic liners, AFOs, and other O&P devices
Vacuum-infusion technology drives concentrated activated oxygen into porous materials where bacteria thrive, outreaching traditional cleaning methods
SUPPORT
BLUEWAVE is not just a device — it’s a wraparound program designed for engagement and measurable ROI.
Enroll – Register members, conduct baseline assessments, device shipped, member + care team training
Engage – Risk-tiered outreach and education, remote utilization monitoring, and proactive check-ins, trouble-shooting
Extend – Integrate into care continuum and support long-term wellness
DATA
Remote Adherence Monitoring – utilization information, including cycle selection, time, frequency, and errors.
Surveys – QoL, satisfaction, patient-reported data
Integration – collaborate to optimize care with data-driven decisions
DEMONSTRATED SUCCESS. IMPROVED CARE.
BLUEWAVE is the only home-based FDA Class II disinfection system designed to target O&P device odor and bacteria.
By addressing vectors of potential infections, BLUEWAVE supports a safer environment for healing and helps prevent costly downstream complications.
Lightweight, at-home, medical-grade disinfection
Targets pathogens that cause infection and odor
Simple-to-use, promotes independence and
self-care
Affordable complement to preventative & value-based care strategies
Remote monitoring ready with easy utilization & adherence data tracking
*The patient testimonials and case studies featured on this site are individual experiences and are provided for informational purposes only. They are not intended to represent or guarantee that anyone will achieve the same or similar results. These statements have not been evaluated by the Food and Drug Administration (FDA), and the outcomes described are not intended to diagnose, treat, cure, or prevent any disease. Results may vary.